4/16
08:40 am
rnxt
RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community [Yahoo! Finance]
High
Report
RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community [Yahoo! Finance]
4/16
08:30 am
rnxt
RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
Medium
Report
RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community
4/4
08:30 am
rnxt
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
Medium
Report
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
4/4
08:14 am
rnxt
RenovoRx, Inc. (NASDAQ: RNXT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Medium
Report
RenovoRx, Inc. (NASDAQ: RNXT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
4/1
08:30 am
rnxt
RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Medium
Report
RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
3/28
08:00 am
rnxt
RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting
Low
Report
RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting
3/27
08:15 am
rnxt
RenovoRx, Inc. (NASDAQ: RNXT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock.
Neutral
Report
RenovoRx, Inc. (NASDAQ: RNXT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock.
3/26
08:53 am
rnxt
RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting [Yahoo! Finance]
Medium
Report
RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting [Yahoo! Finance]
3/26
08:00 am
rnxt
RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting
Low
Report
RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting
3/20
08:00 am
rnxt
RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET
Low
Report
RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET
3/19
08:08 am
rnxt
RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025 [Yahoo! Finance]
Low
Report
RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025 [Yahoo! Finance]
3/19
08:00 am
rnxt
RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025
Low
Report
RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025
2/26
09:09 am
rnxt
RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders [Yahoo! Finance]
Low
Report
RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders [Yahoo! Finance]
2/26
08:00 am
rnxt
RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders
High
Report
RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders
2/13
08:35 am
rnxt
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery [Yahoo! Finance]
High
Report
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery [Yahoo! Finance]
2/13
08:00 am
rnxt
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
High
Report
RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery
2/13
02:25 am
rnxt
Be realistic, responsive and transparent: how to engage underperforming sites [Yahoo! Finance]
High
Report
Be realistic, responsive and transparent: how to engage underperforming sites [Yahoo! Finance]
2/11
07:38 am
rnxt
RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock [Yahoo! Finance]
Low
Report
RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock [Yahoo! Finance]
2/11
07:00 am
rnxt
RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock
Medium
Report
RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock
2/6
08:49 pm
rnxt
RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
Medium
Report
RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
2/6
04:20 pm
rnxt
RenovoRx Announces Proposed Public Offering [Yahoo! Finance]
Medium
Report
RenovoRx Announces Proposed Public Offering [Yahoo! Finance]
2/6
04:16 pm
rnxt
RenovoRx announces proposed public offering [Seeking Alpha]
Low
Report
RenovoRx announces proposed public offering [Seeking Alpha]
2/6
04:05 pm
rnxt
RenovoRx Announces Proposed Public Offering
High
Report
RenovoRx Announces Proposed Public Offering
1/27
08:00 am
rnxt
RenovoRx Highlights Promising Pharmacokinetic Data Abstract Presented at ASCO GI 2025
Medium
Report
RenovoRx Highlights Promising Pharmacokinetic Data Abstract Presented at ASCO GI 2025